Table 1.
EC-factor | Mediatory pathway | Stage | Role(s) | LOF | References | |
---|---|---|---|---|---|---|
EGFL7 | EGFR, AKT(PKB) | E9.0_E11.5 |
• Increase PP proliferation • Decline differentiation to endocrine cells |
• ND | [97, 203] | |
S1P | SPHK, S1P | E10.5 | • Proliferation of PDX1+ PP |
• Declined size of pancreatic buds • Hyper-vascularization |
[204, 205] | |
CTGF | TGFβ, BMPs, Wnts | E12.5 | • β-cell proliferation and islet morphogenesis | • Declined β-cell proliferation and islet vascularity | [206, 207] | |
TSP1 (THBS) | TGFβ-1 | E12.5 |
• Antiangiogenic • Maintain postnatal β-cell function |
• Hyperplasia in islets | [29, 208] | |
HGF | PI3K | E15 | • Increase β-cell proliferation and islet mass |
• Reduced islet size and insulin secretion • Glucose intolerance |
[209–211] | |
BMP 2/4 | TGFβ-1 | ND |
• Stimulate vasculogenesis and angiogenesis • Endothelial progenitor cell differentiation • Mediate GSIS |
• ND | [78, 212] | |
ENDOGLIN | TGFβ | ND | • Islet vascular development | • Decreased insulin secretion | [213] | |
ENDOTHELINs | MAPK, PI3K | ND |
• Stimulate β-cell insulin secretion • Effects on native islet blood vessels |
• Vascular dysfunction | [214, 215] | |
ECM components* | Focal adhesion kinase | ND |
• Increase Insulin gene expression • β-cell differentiation, maturation and survival |
• ND | [29, 216] |
LOF results of loss of function, ND no data provided, EC-factor endothelial cell-factors, EGFL7 epidermal growth factor‐like domain 7, S1P sphingosine-1-phosphate, CTGF connective tissue growth factor, TSP-1 Thrombospondin-1, HGF hepatocyte growth factor, BMP bone morphogenetic protein; VEGF vascular endothelial cell growth factor
*Laminin/Collagen IV/Fibronectin